Literature DB >> 23315075

Self double-stranded (ds)DNA induces IL-1β production from human monocytes by activating NLRP3 inflammasome in the presence of anti-dsDNA antibodies.

Min Sun Shin1, Youna Kang, Naeun Lee, Elizabeth R Wahl, Sang Hyun Kim, Ki Soo Kang, Rossitza Lazova, Insoo Kang.   

Abstract

The pathogenic hallmark of systemic lupus erythematosus is the autoimmune response against self nuclear Ags, including dsDNA. The increased expression of the proinflammatory cytokine IL-1β has been found in the cutaneous lesion and PBMCs from lupus patients, suggesting a potential involvement of this cytokine in the pathogenesis of lupus. IL-1β is produced primarily by innate immune cells such as monocytes and can promote a Th17 cell response, which is increased in lupus. IL-1β production requires cleaving pro-IL-β into IL-1β by the caspase-1-associated multiprotein complex called inflammasomes. In this study we show that self dsDNA induces IL-1β production from human monocytes dependent on serum or purified IgG containing anti-dsDNA Abs by activating the nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome. Reactive oxygen species (ROS) and K(+) efflux were involved in this activation. Knocking down the NLRP3 or inhibiting caspase-1, ROS, and K(+) efflux decreased IL-1β production. Supernatants from monocytes treated with a combination of self dsDNA and anti-dsDNA Ab(+) serum promoted IL-17 production from CD4(+) T cells in an IL-1β-dependent manner. These findings provide new insights in lupus pathogenesis by demonstrating that self dsDNA together with its autoantibodies induces IL-1β production from human monocytes by activating the NLRP3 inflammasome through inducing ROS synthesis and K(+) efflux, leading to the increased Th17 cell response.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23315075      PMCID: PMC3563755          DOI: 10.4049/jimmunol.1201195

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

Review 1.  Antibodies to DNA.

Authors:  B H Hahn
Journal:  N Engl J Med       Date:  1998-05-07       Impact factor: 91.245

2.  Binding properties of human anti-DNA antibodies to cloned human DNA fragments.

Authors:  H Sano; O Takai; N Harata; K Yoshinaga; I Kodama-Kamada; T Sasaki
Journal:  Scand J Immunol       Date:  1989-07       Impact factor: 3.487

3.  Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus.

Authors:  Karin Popovic; Monica Ek; Alexander Espinosa; Leonid Padyukov; Helena Erlandsson Harris; Marie Wahren-Herlenius; Filippa Nyberg
Journal:  Arthritis Rheum       Date:  2005-11

4.  Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9.

Authors:  Terry K Means; Eicke Latz; Fumitaka Hayashi; Mandakolathur R Murali; Douglas T Golenbock; Andrew D Luster
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

5.  Tumor necrosis factor and IL-1 in New Zealand Black/White mice. Enhanced gene expression and acceleration of renal injury.

Authors:  D C Brennan; M A Yui; R P Wuthrich; V E Kelley
Journal:  J Immunol       Date:  1989-12-01       Impact factor: 5.422

6.  Gout-associated uric acid crystals activate the NALP3 inflammasome.

Authors:  Fabio Martinon; Virginie Pétrilli; Annick Mayor; Aubry Tardivel; Jürg Tschopp
Journal:  Nature       Date:  2006-01-11       Impact factor: 49.962

7.  IL-1 beta-deficient mice are resistant to induction of experimental SLE.

Authors:  Elena Voronov; Molly Dayan; Heidy Zinger; Lubov Gayvoronsky; Jian-Ping Lin; Yoichiro Iwakura; Ron N Apte; Edna Mozes
Journal:  Eur Cytokine Netw       Date:  2006-06       Impact factor: 2.737

8.  Preliminary results of safety and efficacy of the interleukin 1 receptor antagonist anakinra in patients with severe lupus arthritis.

Authors:  B Ostendorf; C Iking-Konert; K Kurz; G Jung; O Sander; M Schneider
Journal:  Ann Rheum Dis       Date:  2004-09-02       Impact factor: 19.103

Review 9.  Biologic basis for interleukin-1 in disease.

Authors:  C A Dinarello
Journal:  Blood       Date:  1996-03-15       Impact factor: 22.113

10.  Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus.

Authors:  Franck J Barrat; Thea Meeker; Josh Gregorio; Jean H Chan; Satoshi Uematsu; Shizuo Akira; Bonnie Chang; Omar Duramad; Robert L Coffman
Journal:  J Exp Med       Date:  2005-10-17       Impact factor: 14.307

View more
  47 in total

1.  IL-6 receptor α defines effector memory CD8+ T cells producing Th2 cytokines and expanding in asthma.

Authors:  Naeun Lee; Sungyong You; Min Sun Shin; Won-Woo Lee; Ki Soo Kang; Sang Hyun Kim; Wan-Uk Kim; Robert J Homer; Min-Jong Kang; Ruth R Montgomery; Charles S Dela Cruz; Albert C Shaw; Patty J Lee; Geoffrey L Chupp; Daehee Hwang; Insoo Kang
Journal:  Am J Respir Crit Care Med       Date:  2014-12-15       Impact factor: 21.405

2.  Cholesterol Accumulation in Dendritic Cells Links the Inflammasome to Acquired Immunity.

Authors:  Marit Westerterp; Emmanuel L Gautier; Anjali Ganda; Matthew M Molusky; Wei Wang; Panagiotis Fotakis; Nan Wang; Gwendalyn J Randolph; Vivette D D'Agati; Laurent Yvan-Charvet; Alan R Tall
Journal:  Cell Metab       Date:  2017-05-04       Impact factor: 27.287

Review 3.  Inflammasomes and adaptive immune responses.

Authors:  Katherine A Deets; Russell E Vance
Journal:  Nat Immunol       Date:  2021-02-18       Impact factor: 25.606

Review 4.  Re-Examining Neutrophil Participation in GN.

Authors:  Dawn J Caster; David W Powell; Irina Miralda; Richard A Ward; Kenneth R McLeish
Journal:  J Am Soc Nephrol       Date:  2017-06-15       Impact factor: 10.121

5.  Advances in Disease Mechanisms and Translational Technologies: Clinicopathologic Significance of Inflammasome Activation in Autoimmune Diseases.

Authors:  J Michelle Kahlenberg; Insoo Kang
Journal:  Arthritis Rheumatol       Date:  2020-01-15       Impact factor: 10.995

6.  Differential expression of the inflammasome complex genes in systemic lupus erythematosus.

Authors:  Heidi Lacerda Alves da Cruz; Catarina Addobbati Jordão Cavalcanti; Jaqueline de Azêvedo Silva; Camilla Albertina Dantas de Lima; Thiago Sotero Fragoso; Alexandre Domingues Barbosa; Andréa Tavares Dantas; Henrique de Ataíde Mariz; Angela Luzia Branco Pinto Duarte; Alessandra Pontillo; Sergio Crovella; Paula Sandrin-Garcia
Journal:  Immunogenetics       Date:  2020-02-05       Impact factor: 2.846

7.  An essential role of caspase 1 in the induction of murine lupus and its associated vascular damage.

Authors:  J Michelle Kahlenberg; Srilakshmi Yalavarthi; Wenpu Zhao; Jeffrey B Hodgin; Tamra J Reed; Noriko M Tsuji; Mariana J Kaplan
Journal:  Arthritis Rheumatol       Date:  2014-01       Impact factor: 10.995

8.  Editorial: systemic lupus erythematosus: death by fire and ICE?

Authors:  Westley H Reeves
Journal:  Arthritis Rheumatol       Date:  2014-01       Impact factor: 10.995

9.  Enhanced Inflammasome Activity in Systemic Lupus Erythematosus Is Mediated via Type I Interferon-Induced Up-Regulation of Interferon Regulatory Factor 1.

Authors:  Jianhua Liu; Celine C Berthier; J Michelle Kahlenberg
Journal:  Arthritis Rheumatol       Date:  2017-08-08       Impact factor: 10.995

Review 10.  The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis?

Authors:  J Michelle Kahlenberg; Mariana J Kaplan
Journal:  Curr Opin Rheumatol       Date:  2014-09       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.